|
Volumn 61, Issue 17, 2001, Pages 6372-6376
|
Therapeutic implications of enhanced G0/G1 checkpoint control induced by coculture of prostate cancer cells with osteoblasts
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOXORUBICIN;
KI 67 ANTIGEN;
PACLITAXEL;
PROTEIN P21;
PROTEIN P27;
PROTEIN P53;
RIBONUCLEASE;
THAPSIGARGIN;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
AUTOPSY;
BONE METASTASIS;
CANCER CELL CULTURE;
CELL CYCLE G0 PHASE;
CELL CYCLE G1 PHASE;
CELL PROLIFERATION;
CONTROLLED STUDY;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
IMMUNOHISTOCHEMISTRY;
IN VITRO STUDY;
OSTEOBLAST;
PRIORITY JOURNAL;
PROSTATE CANCER;
REGULATORY MECHANISM;
SCREENING TEST;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL COMMUNICATION;
CELL CYCLE;
CELL DIVISION;
COCULTURE TECHNIQUES;
CULTURE MEDIA, CONDITIONED;
DOXORUBICIN;
G0 PHASE;
G1 PHASE;
HUMANS;
MALE;
NEOPLASMS, HORMONE-DEPENDENT;
OSTEOBLASTS;
PACLITAXEL;
PROSTATIC NEOPLASMS;
THAPSIGARGIN;
TUMOR CELLS, CULTURED;
|
EID: 0035418579
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (58)
|
References (20)
|